Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Palestinian media: Three Palestinians were killed after being targeted by Israeli drone fire in the al-Shujaiya neighborhood east of Gaza City
Nicolas Maduro: The Palestinian cause is the most sacred cause for humanity, and we propose sending teams of builders, farmers, and doctors to Gaza to help the people
Al Mayadeen's correspondent in Lebanon: IOF infiltrate Khallet Wardeh towards the municipality in the town of Aita al-Shaab, south of Lebanon.
Leaders of the United States, Egypt, Qatar, and Turkey sign a ceasefire agreement in Gaza.
Trump arrives in Sharm el-Sheikh
Israeli PM's office: PM informed Trump he would not attend Sharm el-Sheikh Summit on account of Jewish holidays.
Israeli media: Netanyahu makes last-minute decision to cancel trip to Sharm el-Sheikh.
Al Mayadeen's correspondent: Large crowds gather in Khan Younis to welcome the liberated Palestinian detainees, waving flags of Hamas and Islamic Jihad in celebration
Buses of released prisoners arrive in Ramallah
Israeli media: Netanyahu gifts Trump a "Golden Dove".

J&J ends trials for HIV vaccine

  • By Al Mayadeen English
  • Source: News websites
  • 19 Jan 2023 15:58
2 Min Read

The pharmaceutical giant gives up on its HIV vaccine after the shot failed a phase 3 trial.

  • x
  • In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe. (Getty images)
    In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe. (Getty images)

J&J is discontinuing its HIV vaccine after it failed a phase 3 trial, the latest setback in a decades-long quest to prevent one of the world's most heinous diseases.

The world’s largest pharma by revenue said on Wednesday that the trial’s data safety monitoring board found that the shot did not perform any better than placebos. As a result, the Mosaico study will end.

In a statement, Penny Heaton, M.D., Janessen's global vaccine lead, said that the company was disappointed, adding that "we remain steadfast in our commitment to advancing innovation in HIV, and we hope the data from Mosaico will provide insights for future efforts to develop a safe and effective vaccine."

Read next: Scientists might have cured a woman from HIV for the first time

Related News

Trump's aid freeze threatens millions as HIV/AIDS programs collapse

New HIV prevention drug may hit the market at $40 a year per patient

This is considered a major setback for the company and the millions of advocates, activists and global health officials who have worked to tackle HIV once and for all.

J&J discovered that the vaccine was about 25% effective, but the lower end of the confidence interval was less than 0. The Mosaico experiment used a one-year regimen that included four doses of the company's adenovirus vector vaccine, as well as a soluble protein in the third and fourth visits.

The National Institutes of Health and the United States Army Medical Research and Development Command collaborated on this research.

Aside from the public health implications, J&J's failure is the latest in a string of poor vaccine performances. First, the company's one-shot COVID vaccine has nearly vanished from global use; it is one of three shots approved in the United States. Moderna has also surpassed the company in the race to develop an RSV vaccine.

Read next: Moderna, IAVI launch trial for HIV vaccine using mRNA technology

  • AIDS
  • HIV
  • Johnson & Johnson
  • Moderna
  • J&J

Most Read

Palestinian journalist Saleh al-Jaafarawi in an undated image in Gaza, occupied Palestine (Social media)

Gaza Palestinian journalist Saleh al-Jafarawi killed by collaborators

  • Politics
  • 12 Oct 2025
Taylor Swift: The Life of a Showgirl

The Life of a No-Girl: The one verse Taylor Swift refuses to sing

  • Arts and Culture
  • 8 Oct 2025
Iran strikes secret Israeli-US bunker under Tel Aviv high-rise

Tel Aviv high-rise struck by Iran hid Site 81, secret US-Israeli base

  • Politics
  • Today
Ceasefire in Gaza takes effect amid conflicting signals and bombings

Gaza ceasefire takes effect; 'Israel' resumes bombing, timing disputed

  • Politics
  • 9 Oct 2025

Coverage

All
War on Gaza

Read Next

All
US media rejects Pentagon rules limiting access to official info
Politics

US media reject Pentagon rules limiting access to official info

Australia open to sending troops to Middle East post-ceasefire
Politics

Australia open to sending troops to Middle East post-ceasefire

Arab journalists in US say they're being silenced after Gaza coverage
Politics

MENA journalists in US report heightened scrutiny since Gaza war began

Maduro offers Gaza aid and calls for real justice after Sharm El-Sheik.
Latin America

Maduro offers Gaza aid, calls for real justice after Sharm El-Sheikh

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS